Vaxcyte/ US92243G1085 /
| 2024-05-02 9:13:04 PM | Chg. +0.68 | Volume | Bid2024-05-02 | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 64.39USD | +1.07% | 18,129 Turnover: 1.16 mill. |
64.32Bid Size: 206 | -Ask Size: - | 64.95 | 63.11 |
GlobeNewswire
04-30
Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial
GlobeNewswire
04-25
RS BioTherapeutics Adds Jane Wright-Mitchell, Pharm.D., J.D. to Business Advisory Board
GlobeNewswire
04-02
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid t...
GlobeNewswire
03-25
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated...
GlobeNewswire
03-04
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneum...
GlobeNewswire
02-27
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
02-15
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
GlobeNewswire
02-03
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’...
GlobeNewswire
02-01
Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
GlobeNewswire
01-30
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
01-29
Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pne...
GlobeNewswire
01-04
Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC
GlobeNewswire
01-04
Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Con...
GlobeNewswire
2023-12-18
Enterome Appoints Industry Veteran Dr. Peter Hirth to its Board of Directors
GlobeNewswire
2023-12-14
Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta...
GlobeNewswire
2023-12-11
Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (lu...
GlobeNewswire
2023-12-05
VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight B...
GlobeNewswire
2023-11-27
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obta...
GlobeNewswire
2023-11-21
Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer
